GAD1 and type 2 diabetes mellitus: We excluded 294 individuals with non-singleton births, positive GAD (GAD) antibody (>30 kU/l) (to avoid potential misclassification of type 2 diabetes with autoimmune diabetes) or high-sensitivity C-reactive protein (hsCRP) >30 mg/l (indicating acute illness at time of enrolment).